Investigating the gut microbial community and genes in children with differing levels of change in serum asparaginase activity during pegaspargase treatment for acute lymphoblastic leukemia

References

• Story MD, Voehringer DW, Stephens LC, et al. l-Asparaginase kills lymphoma cells by apoptosis. Cancer Chemother Pharmacol. 1993;32(2):129–133.
   PubMed Web of Science ®Google Scholar
• Ueno T, Ohtawa K, Mitsui K, et al. Cell cycle arrest and apoptosis of leukemia cells induced by l-asparaginase. Leukemia. 1997;11(11):1858–1861.
   PubMed Web of Science ®Google Scholar
• Müller HJ, Boos J. Use of l-asparaginase in childhood ALL. Crit Rev Oncol Hematol. 1998;28(2):97–113.
   PubMed Web of Science ®Google Scholar
• Akagi T, Yin D, Kawamata N, et al. Methylation analysis of asparagine synthetase gene in acute lymphoblastic leukemia cells. Leukemia. 2006;20(7):1303–1306.
   PubMed Web of Science ®Google Scholar
• Abaji R, Krajinovic M. Pharmacogenetics of asparaginase in acute lymphoblastic leukemia. Cancer Drug Resist. 2019;2:242–255.
   Google Scholar
• Asselin B, Rizzari C. Asparaginase pharmacokinetics and implications of therapeutic drug monitoring. Leuk Lymphoma. 2015;56(8):2273–2280.
   PubMed Web of Science ®Google Scholar
• Oettgen HF, Stephenson PA, Schwartz MK, et al. Toxicity of E. coli l-asparaginase in man. Cancer. 1970;25(2):253–278.
   PubMedGoogle Scholar
• Peterson RG, Handschumacher RE, Mitchell MS. Immunological responses to l-asparaginase. J Clin Invest. 1971;50(5):1080–1090.
   PubMed Web of Science ®Google Scholar
• Killander D, Dohlwitz A, Engstedt L, et al. Hypersensitive reactions and antibody formation during l-asparaginase treatment of children and adults with acute leukemia. Cancer. 1976;37(1):220–228.
   PubMed Web of Science ®Google Scholar
• Cheung NK, Chau IY, Coccia PF. Antibody response to Escherichia coli l-asparaginase. Prognostic significance and clinical utility of antibody measurement. Am J Pediatr Hematol Oncol. 1986;8(2):99–104.
   PubMedGoogle Scholar
• Woo MH, Hak LJ, Storm MC, et al. Anti-asparaginase antibodies following E. coli asparaginase therapy in pediatric acute lymphoblastic leukemia. Leukemia. 1998;12(10):1527–1533.
   PubMed Web of Science ®Google Scholar
• Woo MH, Hak LJ, Storm MC, et al. Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemia. J Clin Oncol. 2000;18(7):1525–1532.
   PubMed Web of Science ®Google Scholar
• Avramis VI, Sencer S, Periclou AP, et al. A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study. Blood. 2002;99(6):1986–1994.
   PubMed Web of Science ®Google Scholar
• Liu C, Kawedia JD, Cheng C, et al. Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemia. Leukemia. 2012;26(11):2303–2309.
   PubMed Web of Science ®Google Scholar
• Liu Y, Smith CA, Panetta JC, et al. Antibodies predict pegaspargase allergic reactions and failure of rechallenge. J Clin Oncol. 2019;37(23):2051–2061.
   PubMed Web of Science ®Google Scholar
• Hawkins DS, Park JR, Thomson BG, et al. Asparaginase pharmacokinetics after intensive polyethylene glycol-conjugated l-asparaginase therapy for children with relapsed acute lymphoblastic leukemia. Clin Cancer Res. 2004;10(16):5335–5341.
   PubMed Web of Science ®Google Scholar
• Horvath TD, Chan WK, Pontikos MA, et al. Assessment of l-asparaginase pharmacodynamics in mouse models of cancer. Metabolites. 2019;9(1):10.
   Web of Science ®Google Scholar
• Bäckhed F, Ley RE, Sonnenburg JL, et al. Host-bacterial mutualism in the human intestine. Science. 2005;307(5717):1915–1920.
   PubMed Web of Science ®Google Scholar
• Ridlon JM, Kang DJ, Hylemon PB, et al. Bile acids and the gut microbiome. Curr Opin Gastroenterol. 2014;30(3):332–338.
   PubMed Web of Science ®Google Scholar
• Basson A, Trotter A, Rodriguez-Palacios A, et al. Mucosal interactions between genetics, diet, and microbiome in inflammatory bowel disease. Front Immunol. 2016;7:290.
   PubMed Web of Science ®Google Scholar
• Connors J, Dunn KA, Allot J, et al. The relationship between fecal bile acids and microbiome community structure in pediatric Crohn's disease. ISME J. 2020;14(3):702–713.
   PubMed Web of Science ®Google Scholar
• Wikoff WR, Anfora AT, Liu J, et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci USA. 2009;106(10):3698–3703.
   PubMed Web of Science ®Google Scholar
• Visconti A, Le Roy CI, Rosa F, et al. Interplay between the human gut microbiome and host metabolism. Nat Commun. 2019;10(1):4505.
   PubMed Web of Science ®Google Scholar
• Zitvogel L, Daillere R, Roberti MP, et al. Anticancer effects of the microbiome and its products. Nat Rev Microbiol. 2017;15(8):465–478.
   PubMed Web of Science ®Google Scholar
• Comeau AM, Douglas GM, Langille MGI. Microbiome helper: a custom and streamlined workflow for microbiome research. mSystems. 2017;2(1):e00127-16.
   PubMed Web of Science ®Google Scholar
• Rognes T, Flouri T, Nichols B, et al. VSEARCH: a versatile open source tool for metagenomics. PeerJ. 2016;4:e2584.
   PubMed Web of Science ®Google Scholar
• Amir A, McDonald D, Navas-Molina JA, et al. Deblur rapidly resolves single-nucleotide community sequence patterns. mSystems. 2017;2(2):e00191-16.
   PubMed Web of Science ®Google Scholar
• Bolyen E, Rideout JR, Dillon MR, et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol. 2019;37(8):852–857.
   PubMed Web of Science ®Google Scholar
• Shafiei M, Dunn KA, Boon E, et al. BioMiCo: a supervised Bayesian model for inference of microbial community structure. Microbiome. 2015;3:8.
   PubMed Web of Science ®Google Scholar
• Franzosa EA, McIver LJ, Rahnavard G, et al. Species-level functional profiling of metagenomes and metatranscriptomes. Nat Methods. 2018;15(11):962–968.
   PubMed Web of Science ®Google Scholar
• Suzek BE, Wang Y, Huang H, et al. UniRef clusters: a comprehensive and scalable alternative for improving sequence similary searches. Bioinformatics. 2015;31(6):926–932.
   PubMed Web of Science ®Google Scholar
• James G, Witten D, Hastie T, et al. An introduction to statistical learning: with applications in R. New York (NY): Springer; 2017.
   Google Scholar
• Koenig JE, Spor A, Scalfone N, et al. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci USA. 2011;108(Suppl. 1):4578–4585.
   PubMed Web of Science ®Google Scholar
• Yatsunenko T, Rey FE, Manary MJ, et al. Human gut microbiome viewed across age and geography. Nature. 2012;486(7402):222–227.
   PubMed Web of Science ®Google Scholar
• Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–2504.
   PubMed Web of Science ®Google Scholar
• Hastie T, Tibshirani R, Friedman J. The elements of statistical learning: data mining, inference, and prediction. New York (NY): Springer-Verlag; 2001.
   Google Scholar
• Pike M, Kulkarni K, MacDonald T. Asparaginase activity monitoring experience from the Maritimes, Canada. Leuk Lymphoma. 2019;60(9):2312–2315.
   PubMed Web of Science ®Google Scholar
• Zalewska-Szewczyk B, Andrzejewski W, Bodalski J. Development of anti-asparaginase antibodies in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2004;43(5):600–602.
   PubMed Web of Science ®Google Scholar
• Levine A, Kori M, Kierkus J, et al. Azithromycin and metronidazole versus metronidazole-based therapy for the induction of remission in mild to moderate paediatric Crohn's disease: a randomised controlled trial. Gut. 2019;68(2):239–247.
   PubMed Web of Science ®Google Scholar
• Sprockett D, Fischer N, Boneh RS, et al. Treatment-specific composition of the gut microbiota is associated with disease remission in a pediatric Crohn's Disease Cohort. Inflamm Bowel Dis. 2019;25(12):1927–1938.
   PubMed Web of Science ®Google Scholar
• Panosyan EH, Seibel NL, Martin-Aragon S, et al. Asparaginase antibody and asparaginase activity in children with high-risk acute lymphoblastic leukemia: Children’s Cancer Group Study CCG-1961. J Pediatr Hematol Oncol. 2004;26(4):217–226.
   PubMed Web of Science ®Google Scholar
• Kawedia JD, Liu C, Pei D, et al. Dexamethasone exposure and asparaginase antibodies affect relapse risk in acute lymphoblastic leukemia. Blood. 2012;119(7):1658–1664.
   PubMed Web of Science ®Google Scholar
• Vrooman LM, Stevenson KE, Supko JG, et al. Postinduction dexamethasone and individualized dosing of Escherichia coli l-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: results from a randomized study—Dana-Farber Cancer Institute ALL Consortium Protocol 00-01. J Clin Oncol. 2013;31(9):1202–1210.
   PubMed Web of Science ®Google Scholar
• Lorenzi PL, Llamas J, Gunsior M, et al. Asparagine synthetase is a predictive biomarker of l-asparaginase activity in ovarian cancer cell lines. Mol Cancer Ther. 2008;7(10):3123–3128.
   PubMed Web of Science ®Google Scholar
• Chiu M, Taurino G, Bianchi MG, et al. Asparagine synthetase in cancer: beyond acute lymphoblastic leukemia. Front Oncol. 2019;9:1480.
   PubMed Web of Science ®Google Scholar
• Knott SRV, Wagenblast E, Khan S, et al. Asparagine bioavailability governs metastasis in a model of breast cancer. Nature. 2018;554(7692):378–381.
   PubMed Web of Science ®Google Scholar
• Caporaso JG, Lauber CL, Costello EK, et al. Moving pictures of the human microbiome. Genome Biol. 2011;12(5):R50.
   PubMed Web of Science ®Google Scholar
• Zarrinpar A, Chaix A, Yooseph S, et al. Diet and feeding pattern affect the diurnal dynamics of the gut microbiome. Cell Metab. 2014;20(6):1006–1017.
   PubMed Web of Science ®Google Scholar
• Singh RK, Chang HW, Yan D, et al. Influence of diet on the gut microbiome and implications for human health. J Transl Med. 2017;15(1):73.
   PubMed Web of Science ®Google Scholar
• Schwartz DJ, Langdon AE, Dantas G. Understanding the impact of antibiotic perturbation on the human microbiome. Genome Med. 2020;12(1):82.
   PubMed Web of Science ®Google Scholar
• Su N, Pan YX, Zhou M, et al. Correlation between asparaginase sensitivity and asparagine synthetase protein content, but not mRNA, in acute lymphoblastic leukemia cell lines. Pediatr Blood Cancer. 2008;50(2):274–279.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang X, Hu T, et al. Asparagine synthetase expression and its potential prognostic value in patients with NK/T cell lymphoma. Oncol Rep. 2014;32(2):853–859.
   PubMed Web of Science ®Google Scholar
• Perez-Chanona E, Trinchieri G. The role of the microbiota in cancer therapy. Curr Opin Immunol. 2016;39:75–81.
   PubMed Web of Science ®Google Scholar
• Xiao E, He L, Wu Q, et al. Microbiota regulates bone marrow mesenchymal stem cell lineage differentiation and immunomodulation. Stem Cell Res Ther. 2017;8(1):213.
   PubMedGoogle Scholar
• Reed JP, Devkota S, Figlin RA. Gut microbiome, antibiotic use, and immunotherapy responsiveness in cancer. Ann Transl Med. 2019;7(Suppl. 8):S309.
   PubMedGoogle Scholar
• Vicente Dueñas C, Janssen S, Oldenburg M, et al. An intact gut microbiome protects genetically predisposed mice against leukemia. Blood. 2020;136(18):2003–2017.
   PubMed Web of Science ®Google Scholar